跳至主要内容
临床试验/NL-OMON28547
NL-OMON28547已完成不适用

Feasibility of the SENSEI® laparoscopic tethered gamma probe system for 99mTc-nanocolloid sentinel lymph node biopsy in early-stage cervical cancer

MC Utrecht0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • - Age =18 years and able to provide informed consent;
  • - A histopathologically proven primary malignancy of the cervix uteri;
  • - FIGO stage IA1-IB2 or IIA1 (according to the FIGO 2018 guidelines);
  • - Robot-assisted radical surgery is planned with a SLNB and bilateral pelvic lymph node dissection (current standard of care)

排除标准

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • - Pregnancy or current breastfeeding (confirmation by a pregnancy test is the current standard of care).
  • - Prior allergic reaction to 99mTc-nanocolloid.

研究者

发起方
MC Utrecht

相似试验